Trial Profile
Dutasteride can reduce intraoperative bleeding during transurethral resection of the prostate: Evaluation of vascular endothelial growth factor (VEGF) and CD34
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2014
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics
- 15 May 2014 New trial record
- 11 Apr 2014 Results presented at the 29th Congress of the European Association of Urology.